Enzyme−Targeted Therapeutics for Neurological Disorders

Leonardo Massignan, Lokesh Kanduru, Sara Ziadat, David Uehling, Donald F. Weaver, Mark A. Reed

Open source

DOI
10.1021/acs.jmedchem.6c01274
Published
2026-10-10
Container
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.6c01274,
  title = {Enzyme−Targeted Therapeutics for Neurological Disorders},
  author = {Leonardo Massignan and Lokesh Kanduru and Sara Ziadat and David Uehling and Donald F. Weaver and Mark A. Reed},
  year = {2026},
  journal = {Journal of Medicinal Chemistry},
  doi = {10.1021/acs.jmedchem.6c01274},
  url = {https://doi.org/10.1021/acs.jmedchem.6c01274}
}

RIS

TY  - JOUR
TI  - Enzyme−Targeted Therapeutics for Neurological Disorders
AU  - Leonardo Massignan
AU  - Lokesh Kanduru
AU  - Sara Ziadat
AU  - David Uehling
AU  - Donald F. Weaver
AU  - Mark A. Reed
PY  - 2026
JO  - Journal of Medicinal Chemistry
DO  - 10.1021/acs.jmedchem.6c01274
UR  - https://doi.org/10.1021/acs.jmedchem.6c01274
ER  - 

APA

Massignan, L., Kanduru, L., Ziadat, S., Uehling, D., Weaver, D. F., & Reed, M. A. (2026). Enzyme−Targeted Therapeutics for Neurological Disorders. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01274

Source records